LEPU FastRing FR1000
Introduction:
LEPU FastRing FR1000 can be applied for Quickly detecting the function of residual platelet aggregation and predict the risk of thrombosis and monitoring the efficacy of antiplatelet drugs and guide the use of drugs.
参考价:
US$6,000–10,000 / unit
Overview
· Automated platelet aggregation analyzer for rapid platelet function testing.
· Uses optical turbidimetry with an 850 ± 10 nm working wavelength.
· Tests whole blood directly without sample pretreatment.
· Test time of ≤10 minutes according to the current product specification.
· Supports P2Y12 receptor and Cyclooxygenase-1 (COX-1) platelet aggregation testing.
· Helps assess residual platelet aggregation, monitor antiplatelet drug efficacy and support individualized antiplatelet therapy.
· Compact 1.5 kg tabletop design with a 7-inch display.
· Designed for use in cardiology, hemostasis testing and clinical laboratories.
Specifications
| Specification | Details |
|---|---|
| Product Type | Automated Platelet Aggregation Analyzer |
| Model | LEPU FastRing FR 1000 |
| Manufacturer | LEPU Medical |
| Test Principle | Optical Turbidimetry |
| Working Wavelength | 850 ± 10 nm |
| Sample Type | Whole Blood |
| Sample Pretreatment | Not Required |
| Test Time | ≤10 min |
| Test Channels | 1 channel |
| Test Reagents | P2Y12 receptor platelet aggregation reagent card; Cyclooxygenase-1 platelet aggregation reagent card |
| Display | 7-inch |
| Printer | Built-in thermal printer + external printer support |
| Power Supply | AC 220 V, 50 Hz |
| Power Consumption | 48 W |
| Operating Temperature | 5°C–40°C |
| Relative Humidity | 10%–75% |
| Atmospheric Pressure | 860–1060 hPa |
| Weight | 1.5 kg |
| Dimensions | 240 × 230 × 100 mm |
| Configuration | Benchtop |
| Applications | Platelet function testing / Antiplatelet drug monitoring / Thrombosis risk assessment |
Product Details
1. Rapid Platelet Function Testing
The LEPU FastRing FR 1000 is designed to quickly assess residual platelet aggregation and support evaluation of thrombosis risk.
The analyzer uses optical turbidimetry and can analyze whole-blood samples without conventional sample pretreatment, simplifying the testing workflow.
2. Antiplatelet Drug Monitoring
FastRing FR 1000 is designed to monitor the effectiveness of antiplatelet therapy, particularly through testing platelet aggregation pathways associated with P2Y12 receptors and Cyclooxygenase-1.
The corresponding reagent cards include:
· P2Y12 Receptor Platelet Agglutination Test Reagent Card
· Cyclooxygenase-1 Platelet Agglutination Test Reagent Card
These tests can provide information to support antiplatelet treatment decisions.
3. Whole-Blood Testing
One of the main advantages of FastRing FR 1000 is its whole-blood testing workflow. The manufacturer specifies that no sample pretreatment is required.
This reduces sample preparation steps and makes the system suitable for relatively rapid platelet function testing in clinical settings.
4. Compact Point-of-Care Design
The analyzer has a compact footprint of only 240 × 230 × 100 mm and weighs approximately 1.5 kg.
A 7-inch display provides the operating interface, while the integrated thermal printer can be used for test-result documentation.
5. Fast Test Workflow
The current official specification lists a test time of ≤10 minutes. LEPU has also described the FastRing platform in earlier promotional materials as capable of producing results in approximately 3–5 minutes, depending on the test and workflow. Therefore, for a product database, I recommend using the more conservative official specification of ≤10 minutes.













